Keywords
Breast cancer
Mortality
How to Cite
Copyright © | All rights reserved.
The journal holds the exclusive copyright for the publication of this article under the terms of Brazilian law 9610/98.
Partial reproduction
The use of parts of the texts, figures and questionnaire of the article is free, being mandatory the citation of the authors and journal.
Total reproduction
It is expressly prohibited and must be authorized by the journal.
Abstract
Objective: To describe and compare the profile of mortality from malignant breast neoplasms (MBN) in women across the states and regions of Brazil from 2019 to 2023. Methods: This is an ecological, retrospective, time series study using data obtained from the Department of Informatics of the Unified Health System (DATASUS), Mortality Information System (SIM), and the resident population. Female deaths due to MBN (ICD-10: C50) were analyzed. The mortality coefficient (MoC) was calculated, and descriptive and inferential analyses were applied (p<0.05). Results: During the analyzed period, 93,300 deaths were recorded, with the highest concentration in the Southeast region. An increase in the national MoC was observed, from 2.13 to 2.30 between 2019 and 2023. The South region had the highest MoC throughout the period, with an average of 2.54 (95%CI: 2.35–2.72), andamong the states, Rio de Janeiro stood out. Most deaths occurred among white, married women, with 8 to 11 years of schooling, aged between 50 and 59 years, and deaths were mostly recorded in hospitals. Conclusion: The higher MoC for MBN in the South region and in Rio de Janeiro may reflect greater screening coverage and population density. Expanding prevention, diagnosis, and treatment is essential to ensure equitable access and reduce inequalities among Brazilian states and regions.
References
AZAMJAH N, et al. Global trend of breast cancer mortality rate: a 25-year study. Asian Pacific Journal of Cancer Prevention, 2019; 20(7):2015–2020.
BARBOSA IR, COSTA IC, et al. As iniquidades sociais e as disparidades na mortalidade por câncer relativo ao gênero. Revista Ciência Plural, 2015; 1(2):79–86.
BARROS PA, et al. Câncer de Mama em Mulheres Jovens: Análise de 12.689 Casos. Revista Brasileira de Cancerologia, 30 set. 2013; 59(3):351–359.
BRASIL. Censo 2022 mostra que 45% da população brasileira é parda e 43% é branca. Brasília: Agência Gov, 22 dez. 2023. Disponível em: https://agenciagov.ebc.com.br/noticias/202312/censo-2022-mostra-que-45-da-populacao-brasileira-e-pardos-e-43-5-branca. Acesso em: 24 maio 2025.
BRAY F, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians, 2018; 68(6):394–424.
COSTA LD, et al. Mortalidade por câncer de mama e condições de desenvolvimento humano no Brasil. Revista Brasileira de Cancerologia, Rio de Janeiro, 2019; 65(1): e-12050.
FERLAY J, et al. Global Cancer Observatory: Cancer Today [Internet]. Lyon: International Agency for Research on Cancer, [2023]. Disponível em: https://gco.iarc.fr/today. Acesso em: 1 mar. 2025.
GIRIANELLI VR, et al. Os grandes contrastes na mortalidade por câncer do colo uterino e de mama no Brasil. Revista de Saúde Pública, São Paulo, 2014; 48(3):459–467.
GONZAGA CM, et al. Disparities in female breast cancer mortality rates between urban centers and rural areas of Brazil: ecological time-series study. Breast, 2014; 23(2):180–187.
HUANG J, et al. Global incidence and mortality of breast cancer: a trend analysis. Aging, 2021; 13(4):5748–5803.
INTERNATIONAL AGENCY FOR RESEARCH ON CANCER (IARC). Brazil – source: Globocan 2020: incidence, mortality and prevalence by cancer site. Global Cancer Observatory, 2021. Disponível em: https://gco.iarc.fr/today/data/factsheets/populations/76-brazil-fact-sheets.pdf. Acesso em: 31 mar. 2025.
INSTITUTO NACIONAL DE CÂNCER (INCA). Estimativa 2023: incidência de câncer no Brasil. Rio de Janeiro, 2022.
KLUTHCOVSKY AC, et al. Female breast cancer mortality in Brazil and its regions. Revista da Associação Médica Brasileira, São Paulo, 2014; 60(4):387–393.
LEE CS, et al. Rastreamento de câncer de mama em mulheres com 75 anos ou mais. AJR American Journal of Roentgenology, 2018; 210:256–263.
PANIS C, et al. Revisão crítica da mortalidade por câncer usando registros hospitalares e anos potenciais de vida perdidos. Einstein (São Paulo), São Paulo, 2018; 16(1):1–7.
SANTANA GB, et al. Mortalidade por câncer de mama no Brasil entre 1980 e 2010. Revista Portal Saúde e Sociedade, 2021; 6(ed. especial):1–6.
SANTOS MO, et al. Incidência estimada de câncer no Brasil, 2023-2025. Revista Brasileira de Cancerologia, Rio de Janeiro, 2023.
SHANG C, XU. Epidemiology of breast cancer. Oncologie, 2022; 24(4):649–663.
SILVA GR, et al. Tendência da taxa de mortalidade por câncer de mama em mulheres com 20 anos ou mais no Brasil, 2005-2019. Ciência & Saúde Coletiva, Rio de Janeiro, 2024; 29(2):1-11.
SOARES LR, et al. Mortalidade por câncer de mama feminino no Brasil de acordo com a cor. Revista Brasileira de Ginecologia e Obstetrícia, São Paulo, 2015; 37(8):388–392.
TORIOLA AT, COLDITZ GA. Trends in breast cancer incidence and mortality in the United States: implications for prevention. Breast Cancer Research and Treatment, 2013; 138(3):665–673.
TORRE LA, et al. Global cancer incidence and mortality rates and trends—an update. Cancer Epidemiology, Biomarkers & Prevention, 2016; 25(1):16–27.
WORLD HEALTH ORGANIZATION (WHO). Global breast cancer initiative implementation framework: assessing, strengthening and scaling-up of services for the early detection and management of breast cancer [Internet]. 2023. Disponível em: https://www.who.int/initiatives/global-breast-cancer-initiative. Acesso em: 24 maio 2025.
WORLD HEALTH ORGANIZATION (WHO). Breast cancer. 2021. Disponível em: https://www.who.int/news-room/fact-sheets/detail/breast-cancer. Acesso em: 10 jan. 2025.